Codiak BioSciences' GAAP loss for 3 months of 2021 was $10.308 million, down 2.2 times from $22.502 million in the previous year. Revenue increased nearly 100-fold to $13.191 million from $0.134 million a year earlier.
Codiak BioSciences' GAAP loss for 3 months of 2021 was $10.308 million, down 2.2 times from $22.502 million in the previous year. Revenue increased nearly 100-fold to $13.191 million from $0.134 million a year earlier. 
ir.codiakbio.com
English (US) 